110 related articles for article (PubMed ID: 26578182)
1. Antithrombin levels during pediatric cardiopulmonary bypass: Key to changing a decades-old paradigm for anticoagulation?
Andropoulos DB; Fraser CD
J Thorac Cardiovasc Surg; 2016 Feb; 151(2):305-6. PubMed ID: 26578182
[No Abstract] [Full Text] [Related]
2. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
Manlhiot C; Gruenwald CE; Holtby HM; Brandão LR; Chan AK; Van Arsdell GS; McCrindle BW
J Thorac Cardiovasc Surg; 2016 Feb; 151(2):444-50. PubMed ID: 26553458
[TBL] [Abstract][Full Text] [Related]
3. Validation of viscoelastic coagulation tests during cardiopulmonary bypass: reply.
Ortmann E; Klein AA; Besser MW
J Thromb Haemost; 2015 Dec; 13(12):2282. PubMed ID: 26407643
[No Abstract] [Full Text] [Related]
4. Validation of viscoelastic coagulation tests during cardiopulmonary bypass: comment.
Solomon C; Fickenscher K; Ormonde L; Ranucci M
J Thromb Haemost; 2015 Dec; 13(12):2279-81. PubMed ID: 26332686
[No Abstract] [Full Text] [Related]
5. Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: a rebuttal.
Hemker HC; Béguin S
J Thromb Haemost; 2013 Mar; 11(3):564. PubMed ID: 23289967
[No Abstract] [Full Text] [Related]
6. Low-molecular-weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: a reply to rebuttal.
Buyue Y; Misenheimer TM; Sheehan JP
J Thromb Haemost; 2013 Mar; 11(3):565-6. PubMed ID: 23332108
[No Abstract] [Full Text] [Related]
7. Anticoagulation management associated with extracorporeal circulation.
Sniecinski RM; Levy JH
Best Pract Res Clin Anaesthesiol; 2015 Jun; 29(2):189-202. PubMed ID: 26060030
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous use of argatroban and heparin during cardiopulmonary bypass.
Okamura T; Shin'oka T; Ishibashi N; Ishii H; Kurosawa H
Asian Cardiovasc Thorac Ann; 2010 Feb; 18(1):22-6. PubMed ID: 20124292
[TBL] [Abstract][Full Text] [Related]
9. A Pilot Study of Antithrombin Replacement Prior to Cardiopulmonary Bypass in Neonates.
Niebler RA; Woods KJ; Murkowski K; Ghanayem NS; Hoffman G; Mitchell ME; Punzalan RC; Scott JP; Simpson P; Tweddell JS
Artif Organs; 2016 Jan; 40(1):80-5. PubMed ID: 26620919
[TBL] [Abstract][Full Text] [Related]
10. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
Nakahira A; Sasaki Y; Hirai H; Fukui T; Matsuo M; Takahashi Y; Kotani S; Suehiro S
Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):555-60. PubMed ID: 20061337
[TBL] [Abstract][Full Text] [Related]
11. Extreme Plasma Dilution Decreases Heparin and Protamine Cardiopulmonary Bypass Requirements: A Case Report on a Jehovah's Witness Patient.
Chang E; Gatling JW; Bode S; Herrmann PC; Bull BS; Applegate RL
A A Case Rep; 2017 Jun; 8(11):291-293. PubMed ID: 28328588
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation Management and Heparin Resistance During Cardiopulmonary Bypass: A Survey of Society of Cardiovascular Anesthesiologists Members.
Sniecinski RM; Bennett-Guerrero E; Shore-Lesserson L
Anesth Analg; 2019 Aug; 129(2):e41-e44. PubMed ID: 30540616
[TBL] [Abstract][Full Text] [Related]
13. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
[TBL] [Abstract][Full Text] [Related]
14. A case report of heparin resistance due to acquired antithrombin III deficiency.
Leong CK; Ong BC
Ann Acad Med Singap; 1998 Nov; 27(6):877-9. PubMed ID: 10101569
[TBL] [Abstract][Full Text] [Related]
15. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
[TBL] [Abstract][Full Text] [Related]
16. Supplemental Antithrombin Is Effective in Achieving Adequate Anticoagulation in Infants and Children With an Inadequate Response to Heparin.
Lopez M; Feng C; Vasilyeva O; Eaton MP
J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):896-900. PubMed ID: 28242144
[TBL] [Abstract][Full Text] [Related]
17. Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan.
Tanaka KA; Szlam F; Vinten-Johansen J; Cardin AD; Levy JH
Thromb Haemost; 2005 Oct; 94(4):808-13. PubMed ID: 16270635
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
Despotis GJ; Joist JH
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
[TBL] [Abstract][Full Text] [Related]
19. Low heparinization and heparin-bonded circuits.
Hill RC
Ann Thorac Surg; 1997 Oct; 64(4):1221-2. PubMed ID: 9354574
[No Abstract] [Full Text] [Related]
20. Delayed thrombin generation with hirudin anticoagulation during prolonged cardiopulmonary bypass.
Rubens FD; Lavalee G; Ruel MA; Mesana T; Bourke M
Ann Thorac Surg; 2005 Jan; 79(1):334-6. PubMed ID: 15620975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
